Emerging Biomarker-Guided Therapies in Prostate Cancer
Prostate cancer remains one of the leading causes of cancer death in men worldwide.In the past decade, several new treatments Relay for advanced prostate cancer have been approved.With a wide variety of available drugs, including cytotoxic agents, androgen receptor axis-targeted therapies, and alpha-emitting radiation therapy, identifying their opt